During the past decade, Community Research Initiative on AIDS conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 6 clinical trials were completed, i.e. on average, 600% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Community Research Initiative on AIDS" #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "Koronis Pharmaceuticals." with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "Pharmacia and Upjohn" with 2 trials sponsored and "TaiMed Biologics Inc." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Research Initiative on AIDS" #1 collaborator was "AIDS Community Research Initiative of America" with 1 trials as a collaborator, "Grifols Biologicals, LLC" with 1 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Community Research Initiative on AIDS" are "HIV Infections" (17 trials), "HIV" (2 trials), "Lipodystrophy" (2 trials), "Anorexia" (1 trials) and "Body Weight Changes" (1 trials). Many other conditions were trialed in "Community Research Initiative on AIDS" in a lesser frequency.

Most popular intervention types in "Community Research Initiative on AIDS" are "Drug" (21 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (5 trials), "Lamivudine" (4 trials), "Indinavir sulfate" (3 trials), "Delavirdine mesylate" (2 trials) and "KP-1461" (2 trials). Other intervention names were less common.

The vast majority of trials in "Community Research Initiative on AIDS" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Community Research Initiative on AIDS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Community Research Initiative on AIDS, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Community Research Initiative on AIDS, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".